Practical Pediatric HematologyAnupam Sachdeva Evidence-based medicine is the need of the hour. Every pediatrician strives for perfection is his or her practice. These are exciting times for Pediatric Hematology and Oncology. Major advances during the past decade in the field have enhanced the understanding and significantly influenced the management and outcome of many of these chronic and fatal diseases affecting children. While opportunities to learn decrease after one leaves the medical school, science keeps evolving. Keeping this in mind, Indian Academy of Pediatrics (IAP) envisaged starting specialty training under its plan of action 2006. Such trainings keep professional and residents updated about newly launched technologies and other advancements. This book is well illustrated and has many pictures and diagrams for the quick understanding of readers. This will be of use not only to the postgraduates of pediatrics but also will be of immense use to a general pediatrician as a ready-reckoner to be kept on the desk. |
From inside the book
Results 6-10 of 87
Page 20
Anupam Sachdeva. with ITP is usually a well child without fever, hepatosplenomegaly, lymphadenopathy, weight loss or bony tenderness as compared to a patient with bone marrow failure or leukemia who will be a sick child with fever ...
Anupam Sachdeva. with ITP is usually a well child without fever, hepatosplenomegaly, lymphadenopathy, weight loss or bony tenderness as compared to a patient with bone marrow failure or leukemia who will be a sick child with fever ...
Page 22
... Usually, several broad categories can be considered (Table 3.3): 1. Decreased or increased production of RBCs. 2. Size of the red cells—Normal (Normocytic), large (Macrocytic) or small (Microcytic). 3. Impaired production, increased ...
... Usually, several broad categories can be considered (Table 3.3): 1. Decreased or increased production of RBCs. 2. Size of the red cells—Normal (Normocytic), large (Macrocytic) or small (Microcytic). 3. Impaired production, increased ...
Page 23
... usually secondary to an underlying illness, i.e. a primary cause in the hemopoietic system is more frequent in children. Evaluation of the Anemic Patient Diagnostic approach should begin with a detailed history and physical examination ...
... usually secondary to an underlying illness, i.e. a primary cause in the hemopoietic system is more frequent in children. Evaluation of the Anemic Patient Diagnostic approach should begin with a detailed history and physical examination ...
Page 26
... usually normocytic, the reticulocyte index is <2, the E:M ratio is <1:2, and the indirect bilirubin and LDH are normal. In maturation defects, the reticulocyte index is <2, the E:M ratio is >1:1 with severe anemias, the serum LDH and ...
... usually normocytic, the reticulocyte index is <2, the E:M ratio is <1:2, and the indirect bilirubin and LDH are normal. In maturation defects, the reticulocyte index is <2, the E:M ratio is >1:1 with severe anemias, the serum LDH and ...
Page 28
... • Macrocytosis • Erythroblastosis (usually <1% of all nucleated cells) • Leukocytosis and thrombocytosis. Bone Marrow Erythroid hyperplasia. Ferrokinetic • Increased plasma iron turnover 28 Practical Pediatric Hematology.
... • Macrocytosis • Erythroblastosis (usually <1% of all nucleated cells) • Leukocytosis and thrombocytosis. Bone Marrow Erythroid hyperplasia. Ferrokinetic • Increased plasma iron turnover 28 Practical Pediatric Hematology.
Contents
Chapter21 | 156 |
Chapter22 | 165 |
Chapter23 | 178 |
Chapter24 | 181 |
Chapter25 | 199 |
Chapter26 | 208 |
Chapter27 | 232 |
Chapter28 | 247 |
Chapter09 | 69 |
Chapter10 | 75 |
Chapter11 | 85 |
Chapter12 | 90 |
Chapter13 | 97 |
Chapter14 | 115 |
Chapter15 | 120 |
Chapter16 | 125 |
Chapter17 | 130 |
Chapter18 | 144 |
Chapter19 | 148 |
Chapter20 | 153 |
Chapter29 | 259 |
Chapter30 | 262 |
Chapter31 | 266 |
Chapter32 | 272 |
Chapter33 | 281 |
Chapter34 | 289 |
Chapter35 | 298 |
Chapter36 | 305 |
Chapter37 | 309 |
Index | 313 |
Other editions - View all
Common terms and phrases
abnormalities acid activity acute adults antibodies anticoagulant antigen aplastic anemia APTT assay associated bleeding blood loss bone marrow transplantation catheter cause chemotherapy child childhood chronic clinical concentration congenital cytopenia decreased defects develop diagnosis disease disorders Disseminated intravascular coagulation donor dose drugs erythrocyte erythropoietin factor VIII ferritin fetal fibrin fibrinogen folate g/dl gene globin granulocytes Haematol hematocrit hematological hemoglobin hemolysis hemolytic anemia hemophilia hemorrhage heparin hepatitis immune increased India infants infection infusion inhibitor intravenous iron deficiency ischemic laboratory leukemia levels liver malignancy mutations myelodysplastic syndrome myeloid neonatal neutropenia newborn normal nutritional occur oral patients Pediatr peripheral plasma platelet platelet count platelet transfusion present preterm prophylaxis protein prothrombin red cell reticulocyte count risk serum severe splenectomy stem cell stroke studies syndrome Table thalassemia therapy thrombin thrombocytopenia thrombocytosis thrombosis tissue treatment usually venous viral virus vitamin